Core Viewpoint - The China Securities Index for Hong Kong Stock Connect Medical Sector shows a recent upward trend, indicating potential growth in the healthcare sector within the Hong Kong market [1][2]. Group 1: Index Performance - The China Securities Hong Kong Stock Connect Medical Comprehensive Index is currently at 1476.05 points, having increased by 3.68% over the past month, 0.03% over the past three months, and 14.44% year-to-date [1]. - The index is based on a sample of securities classified according to the China Securities Industry Classification Standard, reflecting the overall performance of different industry securities within the Hong Kong Stock Connect [1]. Group 2: Index Holdings - The top ten weighted stocks in the index include JD Health (17.13%), Alibaba Health (14.04%), Sinopharm (11.67%), Weigao Group (7.18%), MicroPort Medical (5.1%), Ping An Good Doctor (4.32%), Shanghai Pharmaceuticals (3.91%), Xianjian Technology (3.56%), Yimaitong (2.93%), and MicroPort Robotics-B (2.88%) [1]. - The index is exclusively composed of stocks listed on the Hong Kong Stock Exchange, with a total market share of 100% [1]. Group 3: Industry Composition - The industry composition of the index shows that pharmaceutical commerce accounts for 49.25%, medical consumables for 23.73%, medical services for 22.88%, medical devices for 3.24%, and in vitro diagnostics for 0.90% [2]. - The index sample is adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2].
中证港股通医疗综合指数报1476.05点，前十大权重包含医脉通等